HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nathaniel Rothman Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2020Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
1/2020Benzene exposure-response and risk of lymphoid neoplasms in Chinese workers: A multicenter case-cohort study.
11/2019Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer.
10/2019Estimation of Source-Specific Occupational Benzene Exposure in a Population-Based Case-Control Study of Non-Hodgkin Lymphoma.
10/2019Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
1/2018Case-control investigation of occupational exposure to chlorinated solvents and non-Hodgkin's lymphoma.
1/2018HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
1/2017Evaluating Exposure-Response Associations for Non-Hodgkin Lymphoma with Varying Methods of Assigning Cumulative Benzene Exposure in the Shanghai Women's Health Study.
10/2016High-resolution metabolomics of occupational exposure to trichloroethylene.
1/2016Bayes and empirical Bayes methods for reduced rank regression models in matched case-control studies.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nathaniel Rothman Research Topics

Disease

98Neoplasms (Cancer)
03/2022 - 11/2002
70Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 11/2002
56Urinary Bladder Neoplasms (Bladder Cancer)
12/2022 - 03/2002
53Lung Neoplasms (Lung Cancer)
10/2022 - 11/2004
23Carcinogenesis
01/2022 - 01/2006
17Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2006
17Lymphoma (Lymphomas)
01/2020 - 04/2007
16Leukemia
01/2019 - 06/2005
16Renal Cell Carcinoma (Grawitz Tumor)
11/2017 - 09/2009
15Inflammation (Inflammations)
01/2022 - 06/2006
15Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 04/2007
13Breast Neoplasms (Breast Cancer)
01/2022 - 02/2008
12Genetic Predisposition to Disease (Genetic Predisposition)
10/2021 - 04/2005
12Multiple Myeloma
01/2021 - 11/2006
11Kidney Neoplasms (Kidney Cancer)
11/2019 - 08/2008
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2008
9Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 11/2006
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 04/2007
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2005
8B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 05/2006
7Obesity
01/2022 - 05/2007
7Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 11/2011
7Adenoma (Adenomas)
01/2019 - 03/2002
6Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 07/2011
6Liver Neoplasms (Liver Cancer)
01/2020 - 01/2016
5Autoimmune Diseases (Autoimmune Disease)
10/2022 - 08/2014
5Chromosome Aberrations (Chromosome Abnormalities)
01/2015 - 03/2004
5Aneuploidy (Aneuploid)
01/2015 - 03/2004
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2016
4Genomic Instability
11/2021 - 10/2006
4Adenocarcinoma
10/2021 - 12/2002
4Carcinoma (Carcinomatosis)
01/2020 - 10/2008
4Glioma (Gliomas)
07/2015 - 08/2008
4Trisomy (Trisomies)
01/2015 - 05/2005
4Monosomy
01/2015 - 05/2005
4Meningioma (Meningiomas)
05/2010 - 09/2005
3Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 05/2014
3Adenocarcinoma of Lung
01/2021 - 08/2010

Drug/Important Bio-Agent (IBA)

33Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2005
31DNA (Deoxyribonucleic Acid)IBA
01/2018 - 12/2002
30Benzene (Benzole)IBA
03/2022 - 05/2005
26ORALIT (ORS)IBA
01/2022 - 09/2005
26CarcinogensIBA
10/2021 - 01/2003
25Biological ProductsIBA
10/2022 - 11/2007
25Coal (Coals)IBA
12/2021 - 11/2004
15CytokinesIBA
04/2020 - 01/2006
14Trichloroethylene (Trichloroethene)IBA
10/2022 - 08/2010
13Proteins (Proteins, Gene)FDA Link
07/2022 - 06/2007
12SmokeIBA
12/2015 - 07/2002
11Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2019 - 11/2004
10Vehicle Emissions (Emissions, Vehicle)IBA
01/2022 - 01/2012
10EnzymesIBA
10/2018 - 04/2005
9SolventsIBA
10/2022 - 01/2009
9Mitochondrial DNA (mtDNA)IBA
01/2015 - 11/2008
9beta Carotene (Betacarotene)FDA Link
12/2014 - 11/2008
9alpha-TocopherolFDA Link
12/2014 - 11/2008
9Interleukin-10 (Interleukin 10)IBA
06/2013 - 01/2006
8Drinking WaterIBA
01/2022 - 01/2007
8Polychlorinated Biphenyls (PCBs)IBA
01/2020 - 12/2005
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2006
8Hair DyesIBA
10/2014 - 07/2006
7Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2018 - 02/2005
7AminesIBA
04/2012 - 03/2002
6fu-yuanIBA
12/2021 - 12/2015
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 06/2010
6Interleukin-6 (Interleukin 6)IBA
12/2012 - 06/2006
5TeaIBA
01/2022 - 04/2005
5TrihalomethanesIBA
01/2022 - 01/2007
5Formaldehyde (Formol)FDA Link
01/2021 - 01/2010
5CarbonIBA
01/2020 - 04/2007
5Folic Acid (Vitamin M)FDA LinkGeneric
12/2018 - 09/2005
5ArsenicIBA
12/2018 - 11/2007
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2017 - 06/2006
57- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA
12/2017 - 11/2006
5Dinoprostone (PGE2)FDA Link
12/2017 - 11/2006
5MetalsIBA
01/2017 - 04/2007
5Messenger RNA (mRNA)IBA
07/2015 - 06/2009
5Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010 - 12/2004
4Environmental Pollutants (Pollutants, Environmental)IBA
10/2022 - 01/2014
4AntibodiesIBA
12/2021 - 10/2016
4Lobeline (Smokeless)IBA
12/2021 - 08/2012
4Benzo(a)pyreneIBA
10/2021 - 08/2005
4MutagensIBA
10/2021 - 08/2006
4ParaffinIBA
01/2021 - 02/2010
4ChemokinesIBA
04/2020 - 07/2013
4LipidsIBA
01/2020 - 12/2005
4AntigensIBA
10/2019 - 03/2012
4AcidsIBA
01/2019 - 11/2009
4Genetic Markers (Genetic Marker)IBA
10/2014 - 05/2009
4P-2 (P 2)IBA
01/2013 - 09/2009
4N-acetyltransferase 1IBA
01/2013 - 08/2006
4AcetyltransferasesIBA
01/2013 - 08/2006
4Vitamin DFDA LinkGeneric
12/2012 - 09/2009
4AntioxidantsIBA
09/2009 - 06/2008
3Hormones (Hormone)IBA
01/2022 - 12/2007
3CoffeeFDA Link
01/2022 - 02/2009
3Estrogens (Estrogen)FDA Link
01/2022 - 12/2007
3InsecticidesIBA
01/2021 - 09/2015
3SootIBA
01/2020 - 10/2016

Therapy/Procedure

5Therapeutics
11/2018 - 07/2007